Source: Zimmer Biomet's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$7.67B
$7.80B
$7.93B
$6.96B
$6.13B
$6.83B
$6.94B
$7.39B
$7.68B
$8.23B
Cost of revenue
$2.38B
$2.13B
$2.27B
$1.94B
$1.82B
$1.96B
$2.02B
$2.08B
$2.19B
$2.49B
Gross profit
$5.29B
$5.67B
$5.66B
$5.02B
$4.30B
$4.87B
$4.92B
$5.31B
$5.49B
$5.74B
Research & development
$365.60M
$369.90M
$391.70M
$394.10M
$322.80M
$435.80M
$406.00M
$458.70M
$437.40M
$458.50M
Selling, general & admin
$2.94B
$3.10B
$3.38B
$2.81B
$2.71B
$2.84B
$2.76B
$2.84B
$2.93B
$3.26B
Operating income
$821.10M
$799.30M
$33.80M
$1.11B
$83.10M
$860.30M
$696.30M
$1.28B
$1.29B
$1.10B
Interest expense
$357.90M
$327.50M
—
—
—
—
—
—
—
—
Pre-tax income
$399.60M
$464.60M
-$271.10M
$880.10M
-$105.20M
$499.00M
$403.50M
$1.07B
$1.04B
$830.80M
Income tax
$95.00M
-$1.35B
$108.20M
-$238.00M
-$96.00M
$53.50M
$112.30M
$42.20M
$131.40M
$125.70M
Net income
$305.90M
$1.81B
-$379.20M
$1.13B
-$138.90M
$401.60M
$231.40M
$1.02B
$903.80M
$705.10M
EBITDA
$1.86B
$1.86B
$1.07B
$1.98B
$981.50M
$1.80B
$1.62B
$2.23B
$2.28B
$2.19B
EPS (basic)
$1.53
$8.98
$-1.86
$5.52
$-0.67
$1.93
$1.10
$4.91
$4.45
$3.56
EPS (diluted)
$1.51
$8.90
$-1.86
$5.47
$-0.67
$1.91
$1.10
$4.88
$4.43
$3.55
Diluted shares
202.40M
203.70M
203.50M
206.70M
207.00M
210.40M
210.30M
209.70M
203.90M
198.70M
Gross margin
68.9%
72.7%
71.4%
72.1%
70.2%
71.3%
70.9%
71.8%
71.5%
69.7%
Operating margin
10.7%
10.2%
0.4%
16.0%
1.4%
12.6%
10.0%
17.3%
16.7%
13.3%
Net margin
4.0%
23.2%
-4.8%
16.3%
-2.3%
5.9%
3.3%
13.8%
11.8%
8.6%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$634.10M
$524.40M
$542.80M
$617.90M
$774.70M
$378.10M
$375.70M
$415.80M
$525.50M
$591.90M
Receivables
$1.60B
$1.54B
$1.28B
$1.36B
$1.28B
$1.26B
$1.38B
$1.44B
$1.48B
$1.70B
Inventory
$1.96B
$2.07B
$2.26B
$2.38B
$2.17B
$2.15B
$2.15B
$2.39B
$2.24B
$2.29B
Total current assets
$4.66B
$4.56B
$4.43B
$4.72B
$5.08B
$4.88B
$4.43B
$4.61B
$4.67B
$5.12B
Goodwill
$10.64B
$10.67B
$9.59B
$9.20B
$8.98B
$8.92B
$8.58B
$8.82B
$8.95B
$9.95B
Total assets
$26.68B
$26.01B
$24.13B
$24.64B
$24.42B
$23.46B
$21.07B
$21.50B
$21.37B
$23.09B
Total current liabilities
$2.38B
$3.07B
$2.42B
$3.44B
$2.56B
$3.47B
$2.36B
$2.86B
$2.45B
$2.58B
Short-term debt
$575.60M
$1.23B
$525.00M
$1.50B
$500.00M
$1.61B
$544.30M
$900.00M
$863.00M
$587.10M
Long-term debt
$10.67B
$8.92B
$8.41B
$6.72B
$7.63B
$5.46B
$5.15B
$4.87B
$5.34B
$6.93B
Total debt
$11.24B
$10.14B
$8.94B
$8.22B
$8.13B
$7.07B
$5.70B
$5.77B
$6.20B
$7.52B
Total liabilities
$17.01B
$14.28B
$12.85B
$12.25B
$12.22B
$10.79B
$9.04B
$9.01B
$8.89B
$10.39B
Shareholders' equity
$9.67B
$11.74B
$11.27B
$12.39B
$12.19B
$12.66B
$12.02B
$12.48B
$12.47B
$12.70B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$1.63B
$1.58B
$1.75B
$1.59B
$1.20B
$1.50B
$1.36B
$1.58B
$1.50B
$1.70B
Capital expenditures
$184.70M
$156.00M
$162.70M
$198.40M
$111.90M
$143.60M
$187.90M
$291.10M
$203.80M
$224.50M
Free cash flow
$1.45B
$1.43B
$1.58B
$1.39B
$1.09B
$1.36B
$1.17B
$1.29B
$1.30B
$1.47B
Investing cash flow
-$1.69B
-$510.80M
-$416.60M
-$729.30M
-$613.80M
-$503.60M
-$522.00M
-$778.90M
-$888.10M
-$1.98B
Financing cash flow
-$743.20M
-$1.21B
-$1.30B
-$779.90M
-$421.80M
-$1.31B
-$775.70M
-$763.50M
-$484.50M
$326.00M
Dividends paid
$188.40M
$193.60M
$195.20M
$196.70M
$198.50M
$200.10M
$201.20M
$200.90M
$196.00M
$190.30M
Share buybacks
$415.50M
—
—
—
—
—
$126.40M
$692.20M
$868.00M
$487.00M
Stock-based compensation
$57.30M
$53.70M
$65.50M
$77.20M
$73.80M
$76.00M
$105.00M
$99.80M
$101.00M
$90.20M
Depreciation & amortization
$1.04B
$1.06B
$1.04B
$871.00M
$898.40M
$937.70M
$926.40M
$951.70M
$996.30M
$1.09B
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$1.94B
$1.89B
$1.94B
$1.82B
$2.02B
$1.91B
$2.08B
$2.00B
$2.24B
$2.09B
$2.18B
$2.06B
Cost of revenue
$538.80M
$512.30M
$553.60M
$538.60M
$586.70M
$549.80M
$592.20M
$559.30M
$792.40M
$576.20M
$635.50M
$594.50M
Gross profit
$1.40B
$1.38B
$1.39B
$1.29B
$1.44B
$1.36B
$1.49B
$1.44B
$1.45B
$1.51B
$1.54B
$1.47B
Research & development
$113.30M
$107.90M
$109.40M
$111.60M
$108.50M
$110.60M
$113.30M
$115.90M
$118.70M
$103.40M
$104.80M
$105.90M
Selling, general & admin
$722.30M
$736.20M
$737.10M
$709.70M
$746.90M
$758.80M
$814.80M
$811.40M
$872.30M
$849.90M
$899.30M
$855.00M
Operating income
$354.20M
$265.90M
$351.30M
$279.50M
$389.00M
$292.30M
$300.00M
$351.30M
$154.50M
$373.20M
$326.10M
$307.60M
Pre-tax income
$284.50M
$215.10M
$302.20M
$230.30M
$289.00M
$229.00M
$224.60M
$279.20M
$98.00M
$301.30M
$255.10M
$230.10M
Income tax
-$135.20M
$42.30M
$59.10M
-$18.90M
$48.90M
$46.50M
$71.20M
$48.00M
-$39.90M
$63.00M
$55.50M
$37.20M
Net income
$419.20M
$172.40M
$242.80M
$249.10M
$239.50M
$182.00M
$152.80M
$230.90M
$139.30M
$238.10M
$198.30M
$191.60M
EBITDA
$595.40M
$504.50M
$594.50M
$530.40M
$652.60M
$546.70M
$571.80M
$634.90M
$438.50M
$643.20M
$596.90M
$589.60M
EPS (basic)
$2.02
$0.84
$1.18
$1.23
$1.20
$0.92
$0.77
$1.17
$0.71
$1.22
$1.03
$1.01
EPS (diluted)
$2.00
$0.84
$1.18
$1.23
$1.19
$0.91
$0.77
$1.16
$0.71
$1.22
$1.03
$1.00
Diluted shares
-400.00K
206.20M
206.40M
203.00M
-1.30M
199.70M
198.30M
198.80M
-300.00K
195.80M
192.80M
191.40M
Gross margin
72.2%
72.9%
71.5%
70.5%
71.0%
71.2%
71.5%
72.1%
64.7%
72.4%
70.8%
71.2%
Operating margin
18.3%
14.1%
18.1%
15.3%
19.2%
15.3%
14.4%
17.6%
6.9%
17.9%
15.0%
14.9%
Net margin
21.6%
9.1%
12.5%
13.7%
11.8%
9.5%
7.4%
11.5%
6.2%
11.4%
9.1%
9.3%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$415.80M
$393.00M
$420.10M
$569.00M
$525.50M
$1.38B
$556.90M
$1.29B
$591.90M
$424.20M
$410.00M
$399.90M
Receivables
$1.44B
$1.45B
$1.42B
$1.48B
$1.48B
$1.53B
$1.61B
$1.60B
$1.70B
$1.73B
$1.77B
$1.82B
Inventory
$2.39B
$2.39B
$2.37B
$2.37B
$2.24B
$2.24B
$2.45B
$2.48B
$2.29B
$2.25B
$2.27B
$2.37B
Total current assets
$4.61B
$4.63B
$4.64B
$4.86B
$4.67B
$5.59B
$5.05B
$5.83B
$5.12B
$4.96B
$5.10B
$5.13B
Goodwill
$8.82B
$8.79B
$8.82B
$8.91B
$8.95B
$8.99B
$9.71B
$9.70B
$9.95B
$9.93B
$9.92B
$10.34B
Total assets
$21.50B
$21.45B
$21.52B
$21.72B
$21.37B
$22.18B
$22.87B
$23.49B
$23.09B
$22.72B
$22.80B
$23.54B
Total current liabilities
$2.86B
$2.80B
$3.61B
$3.57B
$2.45B
$2.29B
$2.70B
$2.40B
$2.58B
$2.86B
$3.01B
$3.50B
Short-term debt
$900.00M
$970.00M
$1.88B
$1.71B
$863.00M
$600.00M
$820.00M
$600.00M
$587.10M
$1.18B
$1.20B
$1.29B
Long-term debt
$4.87B
$4.83B
$3.96B
$4.74B
$5.34B
$6.58B
$6.75B
$7.51B
$6.93B
$6.30B
$6.28B
$6.22B
Total debt
$5.77B
$5.80B
$5.83B
$6.45B
$6.20B
$7.18B
$7.57B
$8.11B
$7.52B
$7.47B
$7.48B
$7.50B
Total liabilities
$9.01B
$8.85B
$8.77B
$9.34B
$8.89B
$9.78B
$10.33B
$10.72B
$10.39B
$10.04B
$10.17B
$10.81B
Shareholders' equity
$12.48B
$12.60B
$12.74B
$12.37B
$12.47B
$12.40B
$12.53B
$12.76B
$12.70B
$12.67B
$12.62B
$12.72B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$588.40M
$228.00M
$369.40M
$395.70M
$506.30M
$382.80M
$378.20M
$418.70M
$517.40M
$359.40M
$447.80M
$560.00M
Capital expenditures
$62.80M
$55.10M
$52.70M
$44.50M
$51.50M
$44.60M
$50.10M
$55.00M
$74.80M
$36.30M
$54.20M
$75.80M
Free cash flow
$525.60M
$172.90M
$316.70M
$351.20M
$454.80M
$338.20M
$328.10M
$363.70M
$442.60M
$323.10M
$393.60M
$484.20M
Investing cash flow
-$220.80M
-$195.00M
-$247.00M
-$154.90M
-$291.20M
-$106.00M
-$1.38B
-$163.30M
-$322.00M
-$159.00M
-$190.80M
-$543.30M
Financing cash flow
-$251.40M
-$50.10M
-$91.90M
-$101.90M
-$240.60M
$575.40M
$163.80M
$483.80M
-$897.00M
-$369.20M
-$271.10M
-$27.20M
Dividends paid
$50.20M
$49.40M
$49.40M
$49.20M
$48.00M
$47.80M
$47.50M
$47.50M
$47.50M
$46.90M
$46.50M
$45.80M
Share buybacks
$410.30M
$113.60M
$85.90M
$596.30M
$72.20M
$229.80M
$7.20M
$0
$250.00M
$250.10M
$250.70M
$78.50M
Stock-based compensation
$25.30M
$29.00M
$26.40M
$24.50M
$21.10M
$19.60M
$21.20M
$25.30M
$24.10M
$24.20M
$24.60M
$24.20M
Depreciation & amortization
$241.20M
$238.60M
$243.20M
$250.90M
$263.60M
$254.40M
$271.80M
$283.60M
$284.00M
$270.00M
$270.80M
$282.00M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.